Overview

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
This is a study of DSP-0390 in patients with recurrent high grade glioma.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sumitomo Dainippon Pharma Oncology, Inc